ClinicalTrialsFinder

Insulin Receptor Mutation Clinical Trials in Bethesda, Maryland

1 recruitingBethesda, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 2

Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

Partial LipodystrophyInsulin Receptor Mutation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)25 enrolled1 locationNCT05470504